"Spicing up" of the immune system by curcumin

Journal of Clinical Immunology

Volumn 27, Issue 1, 2007, Pages 19-35

  Jagetia, Ganesh Chandra ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemokines; Curcumin; Immunomodulation; Interleukins; Nuclear factor B; Tumor necrosis factor

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CURCUMIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGY; ALZHEIMER DISEASE; ASTHMA; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CARDIOVASCULAR DISEASE; DENDRITIC CELL; DIABETES MELLITUS; DRUG EFFECT; ENTERITIS; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; KIDNEY ISCHEMIA; MACROPHAGE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; CURCUMA; CURCUMIN; CYTOKINES; DENDRITIC CELLS; HUMANS; I-KAPPA B PROTEINS; IMMUNOLOGIC FACTORS; LYMPHOCYTES; MACROPHAGES; MICE; MOLECULAR STRUCTURE; NF-KAPPA B; RATS; SPICES;

EID: 33846889718     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-006-9066-7     Document Type: Review

References (170)

1. Dobelis Hamper IN (ed): Magic and Medicine of Plants. Pleasantville, NY, Reader's Digest Association, 1986
2. Srimal RC, Dhawan BN: Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25(6):447-452, 1973
3. Jain SK, DeFilipps RA: Medicinal Plants of India. Algonac, MI, Reference, 1991, p 120
4. Nadkarni AK: Indian Materia Medica, Vol 1. Bombay, India, Popular Book Depot, 1954
5. Chang HM, But BPH: Pharmacology and Applications of Chinese Materia Medica, Vol 2. Philadelphia, PA, World Scientific, 1986, pp 936-939
6. Tu G, Fang Q, Guo J, Yuan S, Chen C, Chen J, Chen Z, Cheng S, Jin R, Li M, et al.: Pharmacopoeia of the People's Republic of China. Guangzhou, P.R. China, Guangdong Science and Technology Press, 1992, pp 202-203
7. Leung A: Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, Wiley, 1980, pp 313-314
8. Lampe V, Milobedeska J, Kostanecki V: Ber Dtsch Chem Ges 43:2163, 1910
9. Lampe V, Milobedeska J: Ber Dtsch Chem Ges 46:2235, 1913
10. Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med 57(1):1-7, 1991
11. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21(4B):2895-2900, 2001
12. Lao CD, Ruffin MT 4th, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE: Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10, 2006
13. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK: Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15(12):1867-1876, 1997
14. Wang F, Wu X, Wang F, Liu S, Jia Z, Yang J: The sensitive method for the determination of curcumin using the enhancement of mixed micelle. J Fluoresc 16(1):53-59, 2006
15. Arora R, Kapoor V, Basu N, Jain AP: Anti-inflammatory studies on Curcuma longa (turmeric). Ind J Med Res 59:1289-1295, 1971
16. Mukhopadhyay A, Basu N, Ghatak N: Anti-inflammatory and irritant activities of curcumin analogues rats. Agents Actions 12:508-515, 1982
17. Srivastava R: Inhibition of neutrophil response by curcumin. Agents Actions 28:298-303, 1989
18. Jobin C, Bradham CA, Russo MP, Juma, B, Narula AS, Brenner DA, Sartor RB: Curcumin blocks cytokine-mediated Nfkappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163:3474-3483, 1999
19. Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK: Antibacterial activity of turmeric oil: A byproduct from curcumin manufacture. J Agric Food Chem 47:4297-4300, 1999
20. Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y: Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmcol 49:1165-1170, 1995
21. Bourne KZ, Bourne N, Reising SF, Stanberry LR: Plant products as topical microbicide candidates: Assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antivir Res 42:219-226, 1999
22. Apisariyakul A, Vanittanakom N, Buddhasukh D: Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 49:163-169, 1995
23. Reddy AC, Lokesh BR: Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. Toxicology 107(1):39-45, 1996
24. Ramsewak RS, DeWitt DL, Nair MG: Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 7:303-308, 2000
25. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R: Antitumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79-83, 1995
26. Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V: Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. J Biosci 28(6):715-721, 2003
27. Garg AK, Buchholz TA, Aggarwal BB: Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 7(11-12):1630-1647, 2005
28. Abraham SK, Sarma L, Kesavan PC: Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage. Mutat Res 303(3):109-112, 1993
29. Rezvani M, Ross GA: Modification of radiation-induced acute oral mucositis in the rat. Int J Radiat Biol 80(2):177-182, 2004
30. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM: Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23:1599-1607, 2004
31. Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE: Curcumin: A new radiosensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132:317-321, 2005
32. Sidhu GS, Singh AK, Thaloor D, Banaudha KK, Patnaik GK, Srimal RC, Maheshwari RK: Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6:167-177, 1998
33. Sidhu GS, Mani H, Gaddipati JP, Singh AK, Seth P, Banaudha KK, Patnaik GK, Maheshwari RK: Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 7:362-374, 1999
34. Jiang MC, Yang-Yen HF, Yen JJ, Lin JK: Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26:111-120, 1996
35. Huang M-T, Lou RY, Ma W, Newmark HL, Reuhl KR, Conney AH: Inhibitory effects of dietary curcumin on forestomach duodenal and colon carcinogenesis in mice. Cancer Res 54:5841-5847, 1994
36. Huang M-T, Smart RC, Wong CQ, Conney AH: Inhibitory effect of curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoyl phorbol-13-acetate. Cancer Res 48:5941-5946, 1988
37. Wang ZY, Georgiadis CA, Laskin JD, Conney AH: Inhibitory effects of curcumin on tumor initiation by benzo(a)pyrene and 7,12-dimethylbenz(a) anthracene. Carcinogenesis 54:5841-5847, 1992
38. Rao CV, Rivenson A, Simi B, Reddy BS: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55:259-266, 1995
39. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE, Lubet RA: Effects of the phytochemicals, curcumin and quercetin upon azoxymethane induced colon cancer and 7,12 dimethylbenz(a)anthracene induced mammary cancer in rats. Carcinogenesis 17:1305-1311, 1996
40. Bhide SV, Azuine MA, Lahiri M, Telang NT: Chemoprevention of mammary tumor virus-induced and chemical carcinogen-induced rodent mammary tumors by natural plant products. Breast Cancer Res Treat 30:233-242, 1994
41. Singletary K, MacDonald C, Wallig M, Fischer C: Inhibition of 7,12-dimethylbenz(a) anthracene (DMBA) induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 103:137-141, 1996
42. Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB, Fini ME: Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275:10405-10412, 2000
43. Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, Williams ML, Steward WP, Gescher AJ: Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11(6):535-540, 2002
44. Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R: Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104(4):879-890, 2005
45. Holy JM: Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res 518:71-84, 2002
46. Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G: Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512:334-340, 2002
47. Aggarwal BB, Kumar A, Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363-398, 2003
48. LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB: Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11(19 Pt 1):6994-7002, 2005
49. Ranjan D, Chen C, Johnston TD, Jeon H, Nagabhushan M: Curcumin inhibits mitogen stimulated lymphocyte proliferation, NF-κB activation, and IL-2 signaling. J Surg Res 121(2):171-177, 2004
50. Ranjan D, Johnston TD, Wu G, Elliott L, Bondada S, Nagabhushan M: Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. J Surg Res 77(2):174-178, 1998
51. Yadav VS, Mishra KP, Singh DP, Mehrotra S, Singh VK: Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 27:485-497, 2005
52. Cipriani B, Borsellino G, Knowles H, Tramonti D, Cavaliere F, Bernardi G, Battistini L, Brosnan CF: Curcumin inhibits activation of Vγ9Vδ2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol 167(6):3454-3462, 2001
53. Sikora E, Bielak-Zmijewska A, Piwocka K, Skierski J, Radziszewska E: Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54(8):899-907, 1997
54. Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Mori N: Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. Leuk Res 30(3):313-321, 2006
55. Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Ohshiro K, Mori N: Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Int J Cancer 118:765-772, 2006
56. Li X, Liu X: Effect of curcumin on immune function of mice. J Huazhong Univ Sci Technol Med Sci 25(2):137-140, 2005
57. Churchill M, Chadburn A, Bilinski RT, Bertagnolli MM: Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89:169-175, 2000
58. Gertsch J, Guttinger M, Heilmann J, Sticher O: Curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells. Bioorg Med Chem 11(6):1057-1063, 2003
59. Kuramoto Y, Yamada K, Tsuruta O, Sugano M: Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. Biosci Biotechnol Biochem 60(10):1712-1713, 1996
60. + ATPases in concanavalin A-stimulated human blood mononuclear cells. Int JMol Sci 4:34-44, 2003
61. Ranjan D, Siquijor A, Johnston TD, Wu G, Nagabhuskahn M: The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. Am Surg 64(1):47-51, 1998
62. Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S: Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93:152-161, 1999
63. Joe B, Lokesh BR: Role of capsaicin, curcumin and dietary n - 3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1224(2):255-263, 1994
64. Joe B, Lokesh BR: Dietary n - 3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages. Mol Cell Biochem 203(1-2):153-161, 2000
65. Bhaumik S, Jyothi MD, Khar A: Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett 483:78-82, 2000
66. South EH, Exon JH, Hendrix K: Dietary curcumin enhances antibody response in rats. Immunopharmacol Immunotoxicol 19(1):105-119, 1997
67. Gao X, Kuo J, Jiang H, Deeb D, Liu Y, Divine G, Chapman RA, Dulchavsky SA, Gautam SC: Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68:51-61, 2004
68. Kim K, Ryu K, Ko Y, Park C: Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells. Br J Haematol 131(1):59-66, 2005
69. Crowley M, Inaba K, Steinman RM: Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med 172:383-386, 1990
70. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296, 1991
71. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen-presenting function of dendritic cells. Curr Opin Immunol 9:10-16, 1997
72. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245-252, 1998
73. Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon DO, Lee CM, Ahn SC, Park YC, Park YM: Curcumin inhibits immunostimulatory function of dendritic cells:MAPKs and translocation of NF-kappa B as potential targets. J Immunol 174(12):8116-8124, 2005
74. Srivastava R: Inhibition of neutrophil response by curcumin. Agents Actions 28(3-4):298-303, 1989
75. Antony S, Kuttan R, Kuttan G: Immunomodulatory activity of curcumin. Immunol Invest 28(5-6):291-303, 1999
76. Ju HR, Wu HY, Nishizono S, Sakono M, Ikeda I, Sugano M, Imaizumi K: Effects of dietary fats and curcumin on IgE-mediated degranulation of intestinal mast cells in brown Norway rats. Biosci Biotechnol Biochem 60(11):1856-1860, 1996
77. Flynn DL, Rafferty MF, Boctor AM: Inhibition of 5-hydroxyeicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22(3):357-360, 1986
78. Bielak-Zmijewska A, Koronkiewicz M, Skierski J, Piwocka K, Radziszewska E, Sikora E: Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr Cancer 38(1):131-138, 2000
79. Chan MM: Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49(11):1551-1556, 1995
80. Lantz RC, Chena GJ, Solyomb AM, Jolad SD, Timmermann BN: The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 12:445-452, 2005
81. Lee JJ, Huang WT, Shao DZ, Liao JF, Lin MT: Blocking NF-kappaB activation may be an effective strategy in the fever therapy. Jpn J Physiol 53(5):367-375, 2003
82. Abe Y, Hashimoto S, Horie T: Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39(1):41-47, 1999
83. Moon DO, Jin CY, Lee JD, Choi YH, Ahn SC, Lee CM, Jeong SC, Park YM, Kim GY: Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: Suppression of p38, JNK and NFkappaB p65 as potential targets. Biol Pharm Bull 29(7):1470-1475, 2006
84. Gulcubuk A, Altunatmaz K, Sonmez K, Haktanir-Yatkin D, Uzun H, Gurel A, Aydin S: Effects of curcumin on tumour necrosis factor-α and interleukin-6 in the late phase of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin Med 53:49-54, 2006
85. Gaddipati JP, Sundar SV, Calemine J, Seth P, Sidhu GS, Maheshwari RK: Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19(2):150-156, 2003
86. Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, Simms HH, Wang P: The anti-inflammatory effect of curcumin in an experimental model of sepsis ismediated by up-regulation of peroxisome proliferator-activated receptor-γ. Crit Care Med 34(7):1874-1882, 2006
87. Jang MK, Sohn DH, Ryu JH: A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria. Planta Med 67(6):550-552, 2001
88. Deeb D, Xu YX, Jiang H, Gao X, Janakiraman N, Chapman RA, Gautam SC: Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2:95-103, 2003
89. Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G, Chapman RA, Dulchavsky SA, Gautam SC: Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-{kappa}B through suppression of I{kappa}B{alpha} phosphorylation. Mol Cancer Ther 3(7):803-812, 2004
90. Jung E, Park MJ, Choi KS, Park J-W, Lee HI, Lee KS, Kwon TK: Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis 27(10):2008-2017, 2006
91. Jung EM, Lim JH, Lee TJ, Park J-W, Choi KS, Kwon TK: Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26:1905-1913, 2005
92. Terry CM, Clikeman JA, Hoidal JR, Callahan KS: Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. Am J Physiol Heart Circ Physiol 274(43):H883-H891, 1998
93. Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, Ikeda O, Mita S, Setoguchi T, Ogawa M: Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95:1206-1214, 2002
94. Wang X, Wang Q, Ives KL, Ever BM: Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin Cancer Res 12(18):5356-5355, 2006
95. Renard P, Delaive E, Van Steenbrugge M, Remacle J, Raes M: Is the effect of interleukin-1 on glutathione oxidation in cultured human fibroblasts involved in nuclear factor-κB activation? Antioxid Redox Signal 3:329-340, 2001
96. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB: Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163(6):3474-3483, 1999
97. Chaudhary LR, Avioli LV: Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J Biol Chem 271:16591-16596, 1996
98. Kang BY, Chung SW, Chung W, Im S, Hwang SY, Kim TS: Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 384(2-3):191-195, 1999
99. Kang BY, Song YJ, Kim KM, Choe YK, Hwang SY, Kim TS: Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 128(2):380-384, 1999
100. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 21:335-376, 2003
101. Youn HS, Saitoh SI, Miyake K, Hwang DH: Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72(1):62-69, 2006
102. Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, Matsuo S: Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 15:1289-1299, 2004
103. Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y: Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 165(10):5767-5772, 2000
104. Mendez-Samperio P, Palma J, Vazquez A: Roles of intracellular calcium and NF-κB in the Bacillus Calmette-Guerin-induced secretion of interleukin-8 from human monocytes. Cell Immunol 211(2):113-122, 2001
105. Nakayama K, Furusu A, Xu Q, Konta T, Kitamura M: Unexpected transcriptional induction of monocytes chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. J Immunol 167(3):1145-1150, 2001
106. Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA, Gautam SC: Curcumin, a compound with anti-inflammatory and anti-oxidant properties, downregulates chemokine expression in bone marrow stromal cells. Exp Hematol 25(5):413-422, 1997
107. Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC: Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11:49-62, 1998
108. Watanabe A, Takeshita A, Kitano S, Hanazawa S: CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun 64(11):4488-4494, 1996
109. Kobayashi T, Hashimoto S, Horie T: Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54(7):819-824, 1997
110. Gupta B, Ghosh B: Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 21(11):745-757, 1999
111. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH: Inhibitory effects of curcumin on in vitro lipooxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51(3):813-819, 1991
112. Tunstall RG, Sharma RA, Perkins S, Sale S, Singh R, Farmer PB, Steward WP, Gescher AJ: Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials. Eur J Cancer 42(3):415-421, 2006
113. Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ: Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-κB activation. Carcinogenesis 24:1515-1524, 2003
114. Lee KW, Kim JH, Lee HJ, Surh YJ: Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 7(11-12):1612-1620, 2005
115. Su CC, Chen GW, Lin JG, Wu LT, Chung JG: Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res 26(2A):1281-1288, 2006
116. Park C, Kim GY, Kim GD, Choi BT, Park YM, Choi YH: Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 15(5):1225-1231, 2006
117. Atsumi T, Murakami Y, Shibuya K, Tonosaki K, Fujisawa S: Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, alpha-diisoeugenol. Anticancer Res 25(6B):4029-4036, 2005
118. Plummer SM, Hill KA, Festing MF, Steward WP, Gescher AJ, Sharma RA: Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev 10(12):1295-1299, 2001
119. Moon Y, Glasgow WC, Eling TE: Curcumin suppresses interleukin 1â-mediated microtonal prostaglandin E syntheses 1 by altering early growth response gene 1 and other signaling pathways. J Pharmacol Exp Ther 315(2):788-795, 2005
120. Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K: Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334(2):313-318, 2005
121. Jiang H, Deng CS, Zhang M, Xia J: Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J Gastroenterol 12(24):3848-3853, 2006
122. Shishodia S, Potdar P, Gairola CG, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaB alpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24(7):1269-1279, 2003
123. Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R: Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology 228(1):1-15, 2006
124. Cho JW, Park K, Kweon GR, Jang BC, Baek WK, Suh MH, Kim CW, Lee KS, Suh SI: Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38MAPkinase and JNK as potential upstream targets. Exp Mol Med 37(3):186-912, 2005
125. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18(44):6013-6020, 1999
126. Goel A, Boland CR, Chauhan DP: Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 172(2):111-118, 2001
127. Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ, Yang CS: Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25(9):1671-1679, 2004
128. Chan MM, Ho CT, Huang HI: Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett 96(1):23-29, 1995
129. Chan MM, Huang HI, Fenton MR, Fong D: In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55(12):1955-1962, 1998
130. Brouet I, Ohshima H: Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206(2):533-540, 1995
131. Singh S, Aggarwal BB: Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane). J Biol Chem 270(42):24995-25000, 1995
132. Shishodia S, Amin HM, Lai, R, Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70:700-771, 2005
133. Brennan P, O'Neill LA: Inhibition of nuclear factor kappaB by direct modification in whole cells - mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol 55(7):965-973, 1998
134. Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K: Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334(2):313-318, 2005
135. Grandjean-Laquerriere A, Gangloff SC, Le Naour R, Trentesaux C, Hornebeck W, Guenounou M: Relative contribution of NF-kB and Ap-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18(3):68-77, 2002
136. Han SS, Keum YS, Seo HJ, Surh YJ: Curcumin suppresses activation of NF-κB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35(3):337-342, 2002
137. Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX: Preventive and therapeutic effects of NF-κB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 11(12):1747-1752, 2005
138. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM: The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21(21):8370-8377, 2001
139. Giri RK, Rajagopal V, Kalra VK: Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91(5):1199-1210, 2004
140. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM: Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280(7):5892-5901, 2005
141. Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M: Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis 10:1-7, 2006
142. Natarajan C, Bright JJ: Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168(12):6506-6513, 2002
143. Nirmala C, Puvanakrishnan R: Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 159(2):85-93, 1996
144. Dikshit M, Rastogi L, Shukla R, Srimal RC: Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res 101:131-135, 1995
145. Cheng H, Liu W, Ai X: Protective effect of curcumin on myocardial ischemia reperfusion injury in rats. Zhong Yao Cai 28(10):920-922, 2005
146. Yao QH, Wang DQ, Cui CC, Yuan ZY, Chen SB, Yao XW, Wang JK, Lian JF: Curcumin ameliorates left ventricular function in rabbits with pressure overload: inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha andmatrix metalloproteinase-2 expression. Biol Pharm Bull 27(2):198-202, 2004
147. Chai H, Yan S, Lin P, Lumsden AB, Yao Q, Chen C: Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. J Am Coll Surg 200(6):8208-8230, 2005
148. Arun N, Nalini N: Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 57(1):41-52, 2002
149. Srivivasan A, Menon VP, Periaswamy V, Rajasekaran KN: Protection of pancreatic beta-cell by the potential antioxidant bis-ohydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J Pharm Pharm Sci 6(3):327-333, 2003
150. Babu PS, Srinivasan K: Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 152(1):13-21, 1995
151. Babu PS, Srinivasan K: Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166(1-2):169-175, 1997
152. Kuroda M, Mimaki Y, Nishiyama T, Mae T, Kishida H, Tsukagawa M, Takahashi K, Kawada T, Nakagawa K, Kitahara M: Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 28(5):937-939, 2005
153. Murugan P, Pari L: Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sci 79(18):1720-1728, 2006
154. Ram A, Das M, Ghosh B: Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull 26(7):1021-1024, 2003
155. Suzuki M, Nakamura T, Iyoki S, Fujiwara A, Watanabe Y, Mohri K, Isobe K, Ono K, Yano S: Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull 28(8):1438-1443, 2005
156. Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, Jacobson K: Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 285(1):G235-G243, 2003
157. Holt PR, Katz S, Kirshoff R: Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 50(11):2191-2193, 2005
158. Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Solyom AM,
159. Jackson JK, Higo T, Hunter WL, Burt HM: The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res 55:168-175, 2006
160. Shoskes D: Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation 66:147-152, 1998
161. Shahed AR, Jones E, Shoskes D: Quercetin and curcumin upregulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury. Transplant Proc 33:2988, 2001
162. Heng MC, Song MK, Harker J, Heng MK: Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143:937-949, 2000
163. Bosman B: Testing of lipooxygenase inhibitors, cyclooxigenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol 7, 324-334, 1994
164. Tourkina E, Gooz P, Oates JC, Ludwicka-Bradley A, Silver RM, Hoffman S: Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase Cε. Respir Cell Mol Biol 31(1):28-35, 2004
165. Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 90(5):1839-1842, 1993
166. Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S, Bahraoui E: Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol 149(1):43-52, 1998
167. Sui Z, Salto R, Li J, Craik C, Ortiz de Montellano PR: Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1(6):415-422, 1993
168. Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y: Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49(8):1165-1170, 1995
169. Vajragupta O, Boonchoong P, Morris GM, Olson AJ: Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett 15(14):3364-3368, 2005
170. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK: Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279(49):51163-51171, 2004